Navigation Links
Caliper Life Sciences Forms Scientific Advisory Board for Next Generation Sequencing
Date:2/19/2010

HOPKINTON, Mass., Feb. 19 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today announced the formation of a scientific advisory board to guide its efforts in automated sample preparation for next generation and third generation sequencing platforms. Caliper worked closely with leading genome centers to develop the LabChip® XT, which was announced today, and is now expanding its efforts to develop additional solutions for next generation sequencing workflows.

"Although tremendous advances have been made in next and third generation sequencing instrumentation and informatics, there remains an unmet need for high quality sample preparation techniques," said Kevin Hrusovsky, President and CEO, Caliper Life Sciences. "We are working with the world renowned members of our Sequencing Advisory Board to identify opportunities that improve sequencing workflows while leveraging Caliper's extensive microfluidics IP estate.  We continue to assess strategic opportunities to directly commercialize products and to out-license our microfluidic technology to collaborators."

Caliper's Sequencing Scientific Advisory Board (SAB) includes the following experts:

Dr. Michael Quail, Wellcome Trust Sanger Institute

Dr. Vincent Magrini, Washington University Genome Sequencing Center

Dr. Patrick Cahill, The Broad Institute of MIT and Harvard

Dr. Christopher Detter, U.S. Department of Energy - Joint Genome Institute

Dr. Jan Fang Cheng, U.S. Department of Energy - Joint Genome Institute

Mr. John Gill, J. Craig Venter Institute

Mrs. Karen Beeson, J. Craig Venter Institute

Several Caliper solutions for next generation sequencing will be presented next week at Advances in Biology and Genomic Technologies (AGBT) in Marco Island, Florida.  Caliper Life Sciences will introduce an Early Access Innovators program for the LabChip XT and will showcase automation and high throughput separation solutions, as well as the fractionation instrument.  For additional information, please visit http://www.caliperLS.com

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper and LabChip are registered trademarks of Caliper Life Sciences, Inc.

SOURCE Caliper Life Sciences, Inc.

Back to top

RELATED LINKS
http://www.caliperls.com

'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
2. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
3. Caliper Life Sciences Presents LabChip(R) Platform to the U.S. Food and Drug Administration
4. Caliper Awarded New Task Order for EPA ToxCast Program
5. Caliper Life Sciences Introduces Sciclone(R) G3 Liquid Handler
6. Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research
7. Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
11. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 2016 , ... Comfort Keepers® of San Diego, CA is excited to announce ... program to drive cancer patients to and from their cancer treatments. Comfort Keepers ... of life and ongoing independence. Getting to and from medical treatments is one ...
Breaking Medicine News(10 mins):